Biotechnology Value Fund, L.P. et al v. Celera Corporporation et al

Filing 181

ORDER DENYING MOTION TO QUASH SUBPOENA AND GRANTING MOTION FOR A PROTECTIVE ORDER. Signed by Judge Alsup on 9/25/2014. (whalc2, COURT STAFF) (Filed on 9/25/2014).

1
2
3
4
5
6

.

7

UNITED STATES DISTRICT COURT

8

NORTHERN DISTRICT OF CALIFORNIA

9

SAN FRANCISCO DIVISION

10
11
12
13
14
15
16
17
18
19

BIOTECHNOLOGY VALUE FUND, L.P.;
BIOTECHNOLOGY VALUE FUND II, L.P.;
INVESTMENT 10, L.L.C.; BVF
INVESTMENTS, L.L.C.; BVF INC.; and BVF X,
LLC,

)
)
)
)
)
)
Plaintiffs,
)
)
v.
)
)
CELERA CORPORATION; CREDIT SUISSE
)
SECURITIES (USA) LLC; KATHY ORDOÑEZ; )
RICHARD H. AYERS; WILLIAM G. GREEN;
)
PETER BARTON HUTT; GAIL M.
)
NAUGHTON; WAYNE I. ROE; and BENNETT )
M. SHAPIRO,
)
)
Defendants.
)

20
21
22
23
24
25
26
27
28
[PROPOSED] ORDER
CASE NO.: CV-13-3248-WHA

CASE NO.: CV-13-3248-WHA
[PROPOSED] ORDER DENYING
MOTION TO QUASH SUBPOENA
AND GRANTING MOTION FOR A
PROTECTIVE ORDER

1

Having considered non-party Pharmacyclics, Inc.’s (“Pharmacyclics”) Motion to Quash

2

Plaintiffs’ Subpoena In Part, Or In The Alternative, For A Protective Order (“Motion”) (ECF No.

3

169), the papers submitted, and the argument of counsel, it is hereby ORDERED that:

4

The Court DENIES Pharmacyclics’ Motion to Quash Subpoena and GRANTS its Motion

5

for A Protective Order. Pharmacyclics shall produce all non-privileged documents responsive to

6

Plaintiffs’ request for Valuation Documents, as defined in Plaintiffs’ letter dated September 10,

7

2014 (ECF No. 165) and Pharmacyclics’ Motion, by 12PM on Monday, September 29, 2014.

8

The Valuation Documents will be produced only to retained litigation counsel of record for

9

the parties in this case (“Outside Counsel”), under a designation of “OUTSIDE COUNSEL ONLY

10

BY COURT ORDER.” In the event Outside Counsel seeks to disclose a document designated

11

“OUTSIDE COUNSEL ONLY BY COURT ORDER” to an expert, client, or any other outside

12

party, Outside Counsel must provide notice to Pharmacyclics and if Pharmacyclics objects to such

13

disclosure, Outside Counsel must seek leave to make such a disclosure from the Court by filing a

14

noticed motion. Upon filing of such a motion, the Court will also consider a request for an

15

expedited briefing schedule on any such motion.

16
17

It Is So Ordered

18
19

September 25
Dated: ________________, 2014 .

________________________________
The Honorable William H. Alsup
United States District Judge

20
21
22
23
24
25
26
27
28
[PROPOSED] ORDER
CASE NO.: CV-13-3248-WHA

-1-